TMC Pharma   Report issue

For profit Phase 3
Founded: Hartley Wintney United Kingdom (2001)

Organization Overview

First Clinical Trial
2018
NCT03610360
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

TMC Pharma | TMC Pharma Services Ltd